Hybrid Molecules with Potential Activity against Drug-resistant Cancer (Part II)

Curr Top Med Chem. 2022;22(17):1392. doi: 10.2174/156802662217220720144604.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents*
  • Humans
  • Neoplasms*

Substances

  • Antineoplastic Agents